Does hepcidin affect erythropoiesis in hemodialysis patients?

Acta Haematologica

Volumn 116, Issue 4, 2006, Pages 238-244

  Eleftheriadis, Theodoros ^a,c   Kartsios, Charalambos ^b   Liakopoulos, Vassilios ^a   Antoniadi, Georgia ^a   Ditsa, Maria ^b   Papadopoulos, Christos ^b   Anifandis, Georgios ^a   Skirta, Aliki ^b   Markala, Dimitra ^b   Stefanidis, Ioannis ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Anemia; Hemodialysis; Hepcidin; Inflammation; Iron

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; FERRITIN; HEPCIDIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL;

AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HEMATOCRIT; HUMANS; IRON; LINEAR MODELS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RENAL DIALYSIS;

EID: 33751258923     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095873     Document Type: Article

References (25)

1. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-7810.
2. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K: LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-150.
3. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S: Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-8785.
4. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S: Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002;99:4596-4601.
5. Frazer DM, Wilkins SJ, Becker EM, Vulpe CD, McKie AT, Trinder D, Anderson GJ: Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002;123:835-844.
6. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-7819.
7. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-2463.
8. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-1044.
9. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S: Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002;29:327-335.
10. Hsu CY: Epidemiology of anemia associated with chronic renal insufficiency. Curr Opin Nephrol Hypertens 2002;11:337-341.
11. Bailie GR, Johnson CA, Mason NA: Parenteral iron use in the management of anemia in end-stage renal disease patients. Am J Kidney Dis 2000;35:1-12.
12. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-476.
13. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999;33:63-72.
14. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001;37(suppl 1):S182-S238.
15. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, Stremmel W: Prohepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 2004;53:735-743.
16. Malyszko J, Malyszko JS, Hryszco T, Pawlak K, Mysliwiec M: Is hepcidin a link between anemia, inflammation and liver function in hemodialysis patients? Am J Nephrol 2005;25:586-590.
17. Taes YE, Wuyts B, Boelaert JR, De Vriese AS, Delanghe JR: Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med 2004;42:387-389.
18. Hörl WH: Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 2002;13:S62-S71.
19. Ludwiczek S, Aigner E, Theurl I, Weiss G: Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003;101:4148-4154.
20. Tarng D-C, Huang T-P: Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients. Nephrol Dial Transplant 2002;17:1063-1069.
21. Deira Lorenzo J, Martinn M, Sanchez S, Tabernero J: Assessment of erythropoiesis activity during hemodialysis therapy by levels and ferrokinetics measurements. Am J Kidney Dis 2001;37:550-556.
22. Castell JV, Andus T, Kunz D, Heinrich PC: Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann NY Acad Sci 1989;557:87-99.
23. Torti FM, Torti SV: Regulation of ferritin genes and protein. Blood 2002;99:3505-3516.
24. Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T: Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood 2005;105:1797-1802.
25. Dallalio G, Law E, Means RT Jr: Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 2006;107:2702-2704.